Lipid raft localization of EGFR alters the response of cancer cells to the EGFR tyrosine kinase inhibitor gefitinib
Author:
Publisher
Wiley
Subject
Cell Biology,Clinical Biochemistry,Physiology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/jcp.22570/fullpdf
Reference61 articles.
1. EGFR inhibitors square off at ASCO;Baker;Nat Biotechnol,2004
2. Cholesterol and other membrane active sterols: From membrane evolution to “rafts;Barenholz;Prog Lipid Res,2002
3. Statin use and the risk of breast cancer;Beck;J Clin Epidemiol,2003
4. Intrinsic and acquired resistance to EGFR inhibitors in human cancer therapy;Bianco;Endocr Relat Cancer,2005
5. Why Iressa failed: Toward novel use of kinase inhibitors (outlook);Blagosklonny;Cancer Biol Ther,2003
Cited by 141 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Busting the Breast Cancer with AstraZeneca’s Gefitinib;Advances in Pharmacological and Pharmaceutical Sciences;2023-12-04
2. Pre-existing cardiometabolic comorbidities and survival of middle-aged and elderly non-small cell lung cancer patients;Journal of Geriatric Cardiology;2023-10
3. Lipid metabolism as a target for cancer drug resistance: progress and prospects;Frontiers in Pharmacology;2023-09-28
4. EGFR trafficking: effect of dimerization, dynamics, and mutation;Frontiers in Oncology;2023-09-11
5. Cholesterol, Eukaryotic Lipid Domains, and an Evolutionary Perspective of Transmembrane Signaling;Cold Spring Harbor Perspectives in Biology;2023-08-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3